|
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
|
1R01CA227466-01
|
$699,062
|
$349,531
|
ZIV, ELAD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
1R01CA227473-01
|
$580,767
|
$580,767
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
|
3R01CA227473-01S1
|
$293,469
|
$293,469
|
HEROLD, KEVAN
|
YALE UNIVERSITY
|
|
Anakinra for neutrophilic pustular skin disease
|
ZIA BC 011550
|
$99,782
|
$89,804
|
Cowen, Edward
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,537,925
|
$61,517
|
Barr, Frederic
|
CCR (NCI)
|
|
Associations of Anti-Parietal Cell and Anti-Intrinsic Factor Antibodies with G
|
ZIA CP010212 10836
|
$21,706
|
$21,706
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Biogenesis, Function and Turnover of Noncoding RNAs
|
ZIA BC 011757
|
$1,384,587
|
$276,917
|
Wolin, Sandra
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$349,312
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
$50,864
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
$17,300
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-35S1
|
$43,750
|
$875
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA082103-19
|
$7,954,381
|
$79,544
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S1
|
$84,000
|
$840
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S2
|
$206,488
|
$2,065
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-19S3
|
$257,838
|
$2,578
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
2P30CA016359-39
|
$4,530,485
|
$135,915
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S1
|
$250,000
|
$7,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S2
|
$60,000
|
$1,800
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S3
|
$56,337
|
$1,690
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016359-39S4
|
$250,000
|
$7,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Cancer risk among Japanese A-bomb survivors
|
ZIA CP010132 04016
|
$20,811
|
$4,162
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
Case referent study of brain tumors in adults
|
ZIA CP010135 04030
|
$207,290
|
$10,364
|
Kitahara, Cari
|
DCEG (NCI)
|
|
CD101 controls intraepithelial cells (IELs) for intestinal barrier integrity
|
ZIA BC 011801
|
$270,196
|
$270,196
|
Wu, Chuan
|
CCR (NCI)
|
|
Cell-free assay technologies for the identification of active compounds
|
ZIA BC 011471
|
$626,698
|
$143,560
|
O'Keefe, Barry
|
CCR (NCI)
|
|
Chronic graft-versus-host disease
|
ZIA BC 011549
|
$888,058
|
$1,175,337
|
Cowen, Edward
|
CCR (NCI)
|
|
Consequences of chronic Interferon-gamma expression on the host
|
ZIA BC 009283
|
$1,117,083
|
$558,541
|
Young, Howard
|
CCR (NCI)
|
|
CPRD: UK Resource for Epidemiologic Research
|
ZIA CP010144 10722
|
$362,499
|
$362,499
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Cytokines and T Cell Development
|
ZIA BC 009287
|
$483,417
|
$96,683
|
Durum, Scott
|
CCR (NCI)
|
|
Defining the Transcriptional Regulation and Genomic Organization of FAIM3 and PIGR, Human Ig Receptors Involved in Immunity, Auto-Immune Disease, and Lymphoma
|
5F31CA221012-02
|
$30,434
|
$15,217
|
ANDREWS, JARED
|
WASHINGTON UNIVERSITY
|
|
Development and function of regulatory T cells
|
ZIA BC 011112
|
$180,127
|
$180,127
|
Singer, Alfred
|
CCR (NCI)
|
|
Diet and obesity related exposures in SEER-Medicare
|
ZIA CP010127 10573
|
$49,993
|
$2,500
|
Freedman, Neal
|
DCEG (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$820,830
|
$82,083
|
Carrington, Mary
|
CCR (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,978,942
|
$395,788
|
Gress, Ronald
|
CCR (NCI)
|
|
Familial aspects of Waldenstrom's macroglobulinemia
|
ZIA CP004410 08300
|
$160,734
|
$48,220
|
Savage, Sharon
|
DCEG (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803 00355
|
$13,239
|
$13,239
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410 08285
|
$76,748
|
$11,512
|
Savage, Sharon
|
DCEG (NCI)
|
|
Glucocorticoids and T cell development and function
|
ZIA BC 011264
|
$298,466
|
$298,465
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
GYN Cancer Epidemiology
|
ZIA CP010128 10766
|
$59,960
|
$5,996
|
Trabert, Britton
|
DCEG (NCI)
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$641,445
|
$128,289
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Histology Core Laboratory
|
ZIC BC 010687
|
$1,365,668
|
$109,253
|
Chinquee, Joseph
|
CCR (NCI)
|
|
Identification of Genetic Factors Associated with Infectious Diseases
|
ZIA BC 010297
|
$252,007
|
$2,520
|
Winkler, Cheryl
|
CCR (NCI)
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,096,433
|
$109,643
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$263,049
|
$131,525
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
Immune-related conditions and risk of gastric cancer in elderly U.S. population
|
ZIA CP010212 10835
|
$10,853
|
$10,853
|
Rabkin, Charles
|
DCEG (NCI)
|
|
Immunophenotyping by CyTOF and machine learning
|
ZIA BC 011807
|
$198,401
|
$39,680
|
Altan-Bonnet, Gregoire
|
CCR (NCI)
|
|
Improving Diagnosis and Management of Cancer Immunotherapy-Induced Hypophysitis
|
5R01CA194042-03
|
$370,575
|
$370,575
|
CATUREGLI, PATRIZIO
|
JOHNS HOPKINS UNIVERSITY
|
|
Innate signaling pathways in colitis and colorectal tumorigenesis
|
5R01CA163507-07
|
$426,313
|
$426,313
|
KANNEGANTI, THIRUMALA-DEVI
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
|
ZIA BC 010853
|
$198,095
|
$19,809
|
Klinman, Dennis
|
CCR (NCI)
|
|
Mechanisms of cell death and autophagy in intestinal epithelial cells in inflammation and cancer
|
5R01CA207177-02
|
$446,063
|
$446,063
|
MOSCAT, JORGE
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIA BC 005270
|
$433,273
|
$64,991
|
Blumberg, Peter
|
CCR (NCI)
|
Total relevant funding to Autoimmune Diseases for this search: $11,075,220
|